535 results on '"Lantuejoul, S."'
Search Results
2. Assessment of the current and emerging criteria for the histopathological classification of lung neuroendocrine tumours in the lungNENomics project
3. Real-world EGFR testing practices for non-small-cell lung cancer by thoracic pathology laboratories across Europe
4. Prise en charge diagnostique et thérapeutique du mésothéliome pleural en 2023: Management of pleural mesothelioma in 2023
5. Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
6. Prise en charge diagnostique et thérapeutique du mésothéliome pleural en 2024
7. Assessment of the current and emerging criteria for the histopathological classification of lung neuroendocrine tumours in the lungNENomics project
8. Que faut-il connaître de la classification anatomopathologique des cancers pulmonaires ?: What do we need to know about the new histomolecular classification of lung cancers?
9. Molecular screening program to select molecular-based recommended therapies for metastatic cancer patients: analysis from the ProfiLER trial
10. P1.20-02 Improved Diagnosis of Lung Neuroendocrine Tumors: Role of Proliferative Activity and Deep Learning
11. MA12.03 New Data from the LungNENomics Project Provide Insights on the Supra-Carcinoid Emerging Variant of Lung Neuroendocrine Tumors
12. CT-texture analysis of subsolid nodules for differentiating invasive from in-situ and minimally invasive lung adenocarcinoma subtypes
13. Multicenter harmonization study for PD-L1 IHC testing in non-small-cell lung cancer
14. Classification histomoléculaire des cancers pulmonaires : quoi de neuf en 2017 ?
15. The immune microenvironment of HPV-negative oral squamous cell carcinoma from never-smokers and never-drinkers patients suggests higher clinical benefit of IDO1 and PD1/PD-L1 blockade
16. Chimiothérapies personnalisées du cancer bronchique : ce que le radiologue doit connaître
17. Prise en charge diagnostique et thérapeutique du mésothéliome pleural malin en 2021: Diagnostic and therapeutic management of malignant pleural mesothelioma in 2021
18. Adénocarcinomes pulmonaires : corrélations entre TDM et histopathologie
19. Lung adenocarcinomas: correlation of computed tomography and pathology findings
20. Personalized chemotherapy of lung cancer: What the radiologist should know
21. Integrative and comparative genomic analyses identify clinically relevant pulmonary carcinoid groups and unveil the supra-carcinoids
22. High-throughput somatic mutation profiling in pulmonary sarcomatoid carcinomas using the LungCarta™ Panel: exploring therapeutic targets
23. OA03.03 The 2024 International Association for the Study of Lung Cancer (IASLC) Global Survey on Biomarker Testing.
24. MA12.07 Defining Morphologic Features of Invasion in Pulmonarynon-Mucinousadenocarcinoma with Lepidic Growth
25. MA02.03 The Evolution of Lung Neuroendocrine Tumors
26. OA04.05 MESOMICS Project: Using Whole-Genome Sequencing Data to Fill the Gaps in Malignant Pleural Mesothelioma Molecular Studies
27. MA01.09 Characterising Aggressive Pulmonary Carcinoids Through Integrative Omics Analysis Within the lungNENomics Project
28. Classification anatomopathologique des cancers pulmonaires et de leurs prénéoplasies
29. Mésothéliome : les dispositifs en place en France « le réseau mésothéliome » 1998–2013
30. Exercise in lung Cancer, the healthcare providers opinion (ECHO): Results of the EORTC lung cancer Group (LCG) survey
31. Translocation EML4-ALK : Techniques de détection, variantes, implications thérapeutiques
32. Tumeurs endobronchiques dans le cadre d’une campagne de détection précoce du cancer bronchique : tomodensitométrie versus endoscopie
33. Endobronchial tumours in a campaign for early detection of bronchial cancer: Computed tomography versus endoscopy
34. Classification histologique des cancers broncho-pulmonaires non à petites cellules
35. CT characteristics of resolving ground-glass opacities in a lung cancer screening programme
36. Imaging of Tumors of the Trachea and Central Bronchi
37. Traitements histoguidés : vers un regain d’intérêt pour le diagnostic histologique des tumeurs pulmonaires
38. Dramatic Improvement in Survival After Lung Transplantation Over Time: A Single Center Experience
39. Imaging of Tumors of the Trachea and Central Bronchi
40. Mucinous adenocarcinoma arising in congenital pulmonary airway malformation: clinicopathological analysis of 37 cases
41. Actualités en pathologie moléculaire dans les cancers du poumon non à petites cellules
42. 147P Non-small cell lung cancer: Artificial intelligence enables the identification of survival signatures complementary to an Immunologically active gene expression signature involving previous therapies
43. Telomere shortening is correlated with the DNA damage response and telomeric protein down-regulation in colorectal preneoplastic lesions
44. Quoi de neuf dans la classification des tumeurs pulmonaires selon l’OMS 2004 ?
45. OA09.03 MESOMICS Project: Molecular Characterization of Malignant Pleural Mesothelioma Using a Multi-Omic Approach
46. Malformaciones broncopulmonares
47. Diagnostic des CBP: Les « puces à ADN » en oncologie thoracique
48. Imagerie des tumeurs bénignes de la plèvre
49. Anatomopathologie des tumeurs et pseudo-tumeurs primitives pleurales
50. Pseudo-acrodermatite entéropathique secondaire à un déficit en acides aminés ramifiés au cours du traitement d’une leucinose
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.